PIEZO1 and chronic kidney disease: Taken together, our results support the hypothesis that CMPF at concentrations observed in advanced CKD stages may prolong PIEZO1 activation in a Jedi1/Jedi2-like fashion and induce structural and functional alterations impairing RBC viability.